Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients-Reference-Cited by-同舟云学术

Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients

Published:2014 Issue:1 Volume:1 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Libuit Jessica¹,Whitman Andrew¹,Wolfe Rebecca¹,Washington Casey S.¹²

Affiliation:

1. Virginia Commonwealth University School of Pharmacy, Falls Church, Virginia

2. Department of Pharmacotherapy and Outcome Sciences

Abstract

Abstract Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/1/1/ofu006/33620805/ofu006.pdf

Reference11 articles.

1. Vancomycin: a 50-year reassessment;Moellering;Clin Infect Dis,2006

2. Empirical antibiotics against gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials;Paul;J Antimicrob Chemother,2005

3. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

4. Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes;Wright;JAMA Intern Med,2013

5. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012;Dellinger;Intensive Care Med,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies;Transplant Infectious Disease;2024-02-13

2. Antimicrobial use and appropriateness in neutropenic fever: a study of the Hospital National Antimicrobial Prescribing Survey data;Journal of Antimicrobial Chemotherapy;2024-02-02

3. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers;Supportive Care in Cancer;2023-11-10

4. Evaluation of glycopeptide prescription in high-risk febrile neutropenia: A monocentric study of North Africa;Journal of Oncology Pharmacy Practice;2023-07-30

5. EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA;Mediterranean Journal of Hematology and Infectious Diseases;2022-04-28